UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000043024
Receipt number R000049102
Scientific Title Clinical utility after changing of artificial intelligence algorithm for cerebral aneurysm diagnosis: A study of consecutive 10,000 cases
Date of disclosure of the study information 2021/01/16
Last modified on 2021/01/15 21:39:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical utility after changing of artificial intelligence algorithm for cerebral aneurysm diagnosis: A study of consecutive 10,000 cases

Acronym

Clinical utility after changing of artificial intelligence algorithm for cerebral aneurysm diagnosis: A study of consecutive 10,000 cases

Scientific Title

Clinical utility after changing of artificial intelligence algorithm for cerebral aneurysm diagnosis: A study of consecutive 10,000 cases

Scientific Title:Acronym

Clinical utility after changing of artificial intelligence algorithm for cerebral aneurysm diagnosis: A study of consecutive 10,000 cases

Region

Japan


Condition

Condition

Unruptured cerebral aneurysm

Classification by specialty

Neurosurgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study was to confirm the clinical utility of UCA diagnosis by changing the existing AI algorithm.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

sensitivity, false positives

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

From December 2018 to July 2019, we extracted 10,000 MRI scans of patients who underwent brain screening using the Brain Dock system.

Key exclusion criteria

Cases with MRI scans outside of the period between December 2018 and July 2019.

Target sample size

10000


Research contact person

Name of lead principal investigator

1st name Fusao
Middle name
Last name Ikawa

Organization

Graduate School of Biomedical and Health Sciences, Hiroshima University

Division name

Department of Neurosurgery

Zip code

7348551

Address

1-2-3 Kasumi, Minami-ku, Hiroshima City, Hiroshima

TEL

0822575227

Email

fikawa-nsu@umin.ac.jp


Public contact

Name of contact person

1st name Fusao
Middle name
Last name Ikawa

Organization

Graduate School of Biomedical and Health Sciences, Hiroshima University

Division name

Department of Neurosurgery

Zip code

7348551

Address

1-2-3 Kasumi, Minami-ku, Hiroshima City, Hiroshima

TEL

0822575227

Homepage URL


Email

fikawa-nsu@umin.ac.jp


Sponsor or person

Institute

Graduate School of Biomedical and Health Sciences, Hiroshima University

Institute

Department

Personal name



Funding Source

Organization

Pfizer Health Research Foundation Japan 2019

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Clinical Research and Investigational Review Board of the Hiroshima University

Address

1-2-3 Kasumi, Minami-ku, Hiroshima City, Hiroshima

Tel

082-257-5907

Email

kasumi-kenkyu@office.hiroshima-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 01 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

10000

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2018 Year 12 Month 01 Day

Date of IRB

2019 Year 07 Month 22 Day

Anticipated trial start date

2018 Year 12 Month 01 Day

Last follow-up date

2023 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Under analysis and before open


Management information

Registered date

2021 Year 01 Month 15 Day

Last modified on

2021 Year 01 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049102


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name